Kurs & Likviditet
Kalender
2024-11-08 | Kvartalsrapport 2024-Q3 |
2024-08-16 | Kvartalsrapport 2024-Q2 |
2024-05-23 | Bonusutdelning RAY B 1.3 |
2024-05-23 | Ordinarie utdelning RAY B 0.70 SEK |
2024-05-22 | Årsstämma 2024 |
2024-05-17 | Kvartalsrapport 2024-Q1 |
2024-02-23 | Bokslutskommuniké 2023 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-26 | Ordinarie utdelning RAY B 0.00 SEK |
2023-05-25 | Årsstämma 2023 |
2023-05-17 | Kvartalsrapport 2023-Q1 |
2023-02-28 | Bokslutskommuniké 2022 |
2022-11-29 | Kvartalsrapport 2022-Q3 |
2022-08-29 | Kvartalsrapport 2022-Q2 |
2022-05-27 | Ordinarie utdelning RAY B 0.00 SEK |
2022-05-25 | Årsstämma 2022 |
2022-05-18 | Kvartalsrapport 2022-Q1 |
2022-02-23 | Bokslutskommuniké 2021 |
2021-11-18 | Kvartalsrapport 2021-Q3 |
2021-08-25 | Kvartalsrapport 2021-Q2 |
2021-05-27 | Ordinarie utdelning RAY B 0.00 SEK |
2021-05-26 | Årsstämma 2021 |
2021-05-05 | Kvartalsrapport 2021-Q1 |
2021-02-23 | Bokslutskommuniké 2020 |
2020-11-18 | Kvartalsrapport 2020-Q3 |
2020-08-26 | Kvartalsrapport 2020-Q2 |
2020-07-01 | Ordinarie utdelning RAY B 0.00 SEK |
2020-06-30 | Årsstämma 2020 |
2020-05-05 | Kvartalsrapport 2020-Q1 |
2020-02-14 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-20 | Kvartalsrapport 2019-Q2 |
2019-05-22 | Ordinarie utdelning RAY B 0.00 SEK |
2019-05-21 | Årsstämma 2019 |
2019-05-09 | Kvartalsrapport 2019-Q1 |
2019-02-20 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-23 | Kvartalsrapport 2018-Q2 |
2018-05-31 | Ordinarie utdelning RAY B 0.00 SEK |
2018-05-29 | Årsstämma 2018 |
2018-05-09 | Kvartalsrapport 2018-Q1 |
2018-02-15 | Bokslutskommuniké 2017 |
2017-11-22 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-24 | Ordinarie utdelning RAY B 0.00 SEK |
2017-05-23 | Årsstämma 2017 |
2017-05-19 | Kvartalsrapport 2017-Q1 |
2017-02-17 | Bokslutskommuniké 2016 |
2016-11-18 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-18 | Ordinarie utdelning RAY B 0.25 SEK |
2016-05-17 | Årsstämma 2016 |
2016-05-12 | Kvartalsrapport 2016-Q1 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-11-25 | Kvartalsrapport 2015-Q3 |
2015-08-28 | Kvartalsrapport 2015-Q2 |
2015-05-29 | Ordinarie utdelning RAY B 0.00 SEK |
2015-05-28 | Årsstämma 2015 |
2015-05-08 | Kvartalsrapport 2015-Q1 |
2015-02-12 | Bokslutskommuniké 2014 |
2014-11-27 | Kvartalsrapport 2014-Q3 |
2014-08-27 | Kvartalsrapport 2014-Q2 |
2014-05-28 | Ordinarie utdelning RAY B 0.00 SEK |
2014-05-27 | Årsstämma 2014 |
2014-05-16 | Kvartalsrapport 2014-Q1 |
2014-02-13 | Bokslutskommuniké 2013 |
2013-11-27 | Kvartalsrapport 2013-Q3 |
2013-08-28 | Kvartalsrapport 2013-Q2 |
2013-05-23 | Ordinarie utdelning RAY B 0.00 SEK |
2013-05-22 | Årsstämma 2013 |
2013-05-16 | Kvartalsrapport 2013-Q1 |
2013-02-14 | Bokslutskommuniké 2012 |
2012-11-16 | Kvartalsrapport 2012-Q3 |
2012-08-28 | Kvartalsrapport 2012-Q2 |
2012-05-31 | Ordinarie utdelning RAY B 0.00 SEK |
2012-05-30 | Årsstämma 2012 |
2012-05-23 | Kvartalsrapport 2012-Q1 |
2012-02-16 | Bokslutskommuniké 2011 |
2011-11-24 | Kvartalsrapport 2011-Q3 |
2011-05-26 | Ordinarie utdelning RAY B 0.50 SEK |
2011-05-25 | Årsstämma 2011 |
2011-05-04 | Kvartalsrapport 2011-Q1 |
2011-02-18 | Bokslutskommuniké 2010 |
2010-11-12 | Kvartalsrapport 2010-Q3 |
2010-08-27 | Kvartalsrapport 2010-Q2 |
2010-05-26 | Ordinarie utdelning RAY B 0.50 SEK |
2010-05-25 | Årsstämma 2010 |
2010-05-11 | Kvartalsrapport 2010-Q1 |
2009-11-20 | Kvartalsrapport 2009-Q3 |
2009-08-27 | Kvartalsrapport 2009-Q2 |
2009-05-27 | Ordinarie utdelning RAY B 0.00 SEK |
2009-05-26 | Årsstämma 1 |
2009-05-15 | Kvartalsrapport 2009-Q1 |
2008-06-25 | Split RAY B 1:3 |
2003-06-10 | Split RAY B 20:1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
RaySearch Laboratories AB (publ) announces that the Mass General Cancer Center plans to expand its use of RayStation®* to proton treatment planning.
RayStation is a flexible, innovative cancer treatment planning system developed by RaySearch. The software offers features for proton therapy planning such as multi-criteria optimization, LET evaluation, and optimization, as well as modalities under development such as proton arcs and FLASH.
The Mass General Cancer Center, which was the first in the world to offer proton therapy, is in the process of transitioning its proton treatment planning system to RayStation. The center has been using RayStation for photon radiation therapy planning for more than 10 years. By expanding its clinical use to include protons, all external beam planning will now be done on a single platform.
David Gierga, PhD, Director of Clinical Physics Operations in Radiation Oncology at the Mass General Cancer Center, says: "We are excited to streamline our treatment planning operations and look forward to having access to new and exciting developments in proton planning."
Harald Paganetti, PhD, Director of Physics Research in Radiation Oncology at the Mass General Cancer Center, says: "We have had access to RayStation for many years, and my team and I are pleased that the system soon will be used clinically for proton planning as well as. This will expedite the translation of research findings and new technologies into the clinic."
Johan Löf, founder and CEO, RaySearch, says: "Mass General is truly a pioneering collaboration partner to RaySearch. They were one of the very first users of RayStation in the world and we have benefitted greatly from various collaboration projects that we have done together during the years. I am happy that they now have the opportunity to start using RayStation also for their proton treatments."
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com